AKER HAZEL M 4
4 · GTX INC /DE/ · Filed Jun 11, 2019
Insider Transaction Report
Form 4
GTX INC /DE/ONCT
AKER HAZEL M
General Counsel
Transactions
- Award
Common Stock
2019-06-07+5,015→ 5,015 total(indirect: By Trust) - Award
Common Stock
2019-06-07+4,284→ 4,284 total - Award
Warrants
2019-06-07+140→ 140 total(indirect: By Trust)Exercise: $6.13Exp: 2022-09-12→ Common Stock (140 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger dated as of April 30, 2019 (the "Merger Agreement"), by and among Oncternal Therapeutics, Inc. ("Old Oncternal"), GTx, Inc. ("GTx") and certain of their subsidiaries, on June 7, 2019 (the "Effective Time"), GTx was merged with and into Old Oncternal, with GTx surviving as the continuing entity. At the Effective Time, each share of Old Oncternal common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.073386 shares of the Issuer's common stock. On the trading day immediately prior to the effective time, the closing price of the Issuer's common stock was $1.20 per share.
- [F2]The warrants are currently exercisable.